Peel Hunt reaffirmed their buy rating on shares of Genedrive (LON:GDR) in a research report report published on Tuesday morning, ThisIsMoney.Co.Uk reports.
Shares of Genedrive stock opened at GBX 21.50 ($0.28) on Tuesday. The firm has a 50-day moving average of GBX 19.22 and a 200-day moving average of GBX 18.83. Genedrive has a 52-week low of GBX 13 ($0.17) and a 52-week high of GBX 30 ($0.39). The stock has a market cap of $7.31 million and a PE ratio of -1.54.
In other Genedrive news, insider Ian David Gilham acquired 48,000 shares of the company’s stock in a transaction on Friday, November 22nd. The stock was acquired at an average price of GBX 21 ($0.27) per share, for a total transaction of £10,080 ($13,171.31).
genedrive plc, a molecular diagnostics company, engages in developing and commercializing point of need diagnostics platform for infectious diseases, genotyping, pathogen detection, and other indications. It operates through three divisions: Preclinical Research Services, Pharmacogenomic Services, and Diagnostics.
Read More: Preferred Stock
Receive News & Ratings for Genedrive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genedrive and related companies with MarketBeat.com's FREE daily email newsletter.